Powered by Smartsupp

Nattokinase and vitamin K2: what is the difference and what is FU?

KINGRAY Academy · 11

What is the difference between nattokinase and vitamin K2?

Nattokinase is an enzyme produced during natto fermentation; vitamin K2 is a group of menaquinones. A shared food source does not make them the same substance. Find concise answers, a worked FU calculation and research findings with their limitations below. [1] [2]

Author: Ing. František KokošPublished: Updated:

Substances and ingredients

You asked us

01 · Is nattokinase vitamin K2?

No. The enzyme nattokinase and vitamin K2 differ in chemical structure and function. Natto as a food can contain both. [1] [2]

02 · What does FU mean in nattokinase?

FU expresses enzyme activity in breaking down fibrin in a defined laboratory test. It is neither a unit of mass nor a measure of how many clots will dissolve in the body. [1]

03 · Is 2,000 FU/g the same as 2,000 FU per capsule?

No. A per-gram figure must be converted using the mass of the relevant ingredient. A worked example appears below; milligrams alone do not determine activity. [1]

04 · Does every nattokinase extract contain K2?

Not necessarily. Composition depends on processing and any added vitamin. The words “natto” or “nattokinase” alone do not establish the K2 content. [1] [2]

05 · Does swallowed nattokinase dissolve blood clots?

Breaking down fibrin in a laboratory does not establish effective treatment of thrombosis in humans. A small trial measured blood markers, not clot removal. Do not replace prescribed treatment with it. [3]

06 · Does nattokinase lower blood pressure?

Findings are inconsistent. A shorter trial reported lower blood pressure; longer follow-up in low-risk people did not confirm a benefit. The research section explains the figures and differences. [4] [5]

07 · Does vitamin K2 remove calcium from arteries?

That effect cannot be promised. Vitamin K supports proteins involved in calcification, but clinical findings are inconclusive. It contributes to normal clotting and bones; it is not an “artery-cleansing” medicine. [2] [6]

08 · Can I combine nattokinase with warfarin or aspirin?

Do not start this combination yourself: bleeding risk may increase. K2 can affect warfarin. These substances cannot be safely used to “balance out” each other. [2] [7]

09 · What dose and time of day are best?

These studies do not establish a universal treatment dose or best time of day. A research dose is not a personal recommendation. Any use depends on the specific label, health circumstances and medicines. [1] [3] [4] [5]

10 · Is a K2-free product automatically safe?

No. Removing K2 does not remove possible risks from the enzyme or other ingredients. Composition, allergens and warnings need consideration together. [8]

Three different terms

Natto

A fermented soybean food containing several constituents. A serving of natto is not equivalent to a dose of isolated extract. [1] [2]

Nattokinase

A protein enzyme that can break down fibrin in laboratory conditions. Fibrin forms the mesh that stabilises a blood clot. [1] [2]

Vitamin K2

A family of fat-soluble vitamins, including MK-4 and MK-7. K2 is not an enzyme; its amount is stated in micrograms. [1] [2]

Schematic illustration of a fibrin mesh with red blood cells
Illustration of a fibrin mesh, not a micrograph or evidence of a supplement effect.

FU and milligrams

mg indicates ingredient mass; FU indicates measured enzyme activity. First check whether the figure is per gram, per capsule or per daily serving. [1]

Worked example, not a recommended dose: 100 mg = 0.1 g. At 2,000 FU/g this provides 200 FU; at 20,000 FU/g it provides 2,000 FU. Without declared activity, milligrams cannot be converted to FU.

Simply put: Equal masses of two extracts need not have equal activity. Equal FU values do not guarantee equal outcomes in people either.

What did the studies find?

2015 · Short-term blood markers

12 healthy men · one 2,000 FU dose · 8 hours

A placebo-controlled crossover trial found changes in some clotting and fibrinolysis markers, all within normal ranges. It did not test heart attack prevention or thrombosis treatment. [3]

2008 · Blood pressure

86 enrolled / 73 completed · 2,000 FU daily · 8 weeks

Versus placebo, systolic pressure fell by approximately 5.55 and diastolic by 2.84 mmHg. This short trial does not establish heart attack prevention. [4]

2021 · NAPS

265 participants · 2,000 FU daily · median 3 years

In healthy, low-risk adults, carotid wall thickness and stiffness progression and blood pressure did not differ significantly from placebo. [5]

Trials used specific preparations and different populations. Their findings cannot automatically apply to every product. Blood viscosity, clotting and clot breakdown are different processes.

Read more: vitamin K1 and K2, MK-7 and medicine interactions →

What does the EFSA opinion mean?

The 2016 EFSA opinion assessed the safety of a specific fermented soybean extract, NSK-SD®, under defined conditions. It does not approve disease treatment or establish the effectiveness of all nattokinase products. [1]

For this specified extract, the EU list permits a maximum of 100 mg daily for adults, excluding pregnant and breastfeeding women; medical supervision is required with medication. These are conditions for a specific ingredient, not a universal treatment dose of nattokinase. [8]

The EU authorises vitamin K claims about normal blood clotting and maintenance of normal bones when the conditions of use are met. These claims do not transfer to nattokinase. [6]

Medicines and safety

If you take medicines, use of the authorised fermented soybean extract requires medical supervision. Do not independently change prescribed treatment. [8]

With warfarin and other vitamin K antagonists, a consistent vitamin K intake matters. Discuss changes to food or K2 with your treating clinician. [2]

Tell your clinical team about all preparations before a procedure. Check ingredients if allergic to soy; adult studies do not establish use in children, pregnancy or breastfeeding. [1] [8]

Continue the ingredients series: digestive enzymes, betaine HCl and pepsin →

Sources

Numbered links connect statements to sources. For papers 4 and 5, the abstracts were reviewed; for paper 3, the full text.

[1] EFSA (2016): safety of the specific NSK-SD® extract, composition and FU activity.

[2] NIH ODS: vitamin K, menaquinones, calcification research and warfarin.

[3] Kurosawa et al. (2015): a single nattokinase dose and blood markers.

[4] Kim et al. (2008): randomised nattokinase and blood pressure trial — abstract.

[5] Hodis et al. (2021): NAPS, a long-term randomised trial — abstract. · ClinicalTrials.gov · NCT02080520

[6] Regulation (EU) No 432/2012: authorised vitamin K health claims.

[7] Memorial Sloan Kettering: nattokinase warnings and medicine interactions.

[8] EU novel foods list: fermented soybean extract specification and conditions of use.

Ing. František Kokoš
Author: Ing. František Kokoš
Ing. František Kokoš – Author of KINGRAY Academy and Advice Corner
Technician, nutrition adviser (graduate of the 150-hour Welko retraining programme, 2025) and creator of the KINGRAY nutraceuticals concept. Years of developing the BIOquant medical device and working with blood rheology and tissue oxygenation led him to realise that bodily health requires the full picture – linking microcirculation, cellular energy and proper nutrition. In his articles, he looks for the balance where the body understands and cooperates with us.
He is the author of the book Liečba svetlom (Light Therapy, ISBN 978-80-970512-0-4), co-author of the publication BIOquant – polovodičová laserová terapia (BIOquant – Semiconductor Laser Therapy, ISBN 978-80-970512-2-8), and originator of patents in light technologies (US9731145B2, SK5457Y1).
%s ...
%s
%image %title %code %s
%s